A Pennsylvania federal judge has allowed the majority of claims to proceed against Merck & Co. in a qui tam suit and related antitrust putative class action over the company’s testing and government sales of its mumps vaccine.

U.S. District Judge C. Darnell Jones II of the Eastern District of Pennsylvania issued one opinion Friday in two related suits—United States v. Merck & Co. and Chatom Primary Care v. Merck & Co.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]